#Canada #Toronto #Xtalks #Therapy Development #Peptide Conjugates

Peptide Conjugates: Technologies and Therapeutic Applications

The therapeutic landscape today is witnessing rapid advancements, particularly in the field of peptide conjugates. These innovative therapies have gained significant attention and commercial success, with over 300 peptide-drug conjugates currently under clinical development. To share insights on the synthesis and development of these complex molecules, Xtalks is hosting a free webinar titled "The Expanding Peptide Conjugate Landscape: Strategies for Complex Peptide Synthesis."

Understanding Peptide Conjugates

Peptide conjugates, which typically consist of a peptide linked to a therapeutic agent, have shown promise due to their targeted delivery and reduced side effects compared to traditional small molecule drugs. As their use becomes more widespread, there is a burgeoning interest in various types of conjugates, including peptide-drug conjugates (PDCs), radionuclide-drug conjugates (RDCs), and antibody-peptide conjugates (APCs).

This increasing complexity in design presents unique challenges in synthesis. Factors like peptide structure, the properties of linkers and payloads, and conjugation chemistry are all critical components for successful development. During the upcoming webinar, experts will delve into the methodologies used to tackle these synthesis challenges.

Key Focus Areas

The webinar will cover essential topics, including:

• - Route Selection: Choosing the optimal synthesis pathways to achieve desired outcomes.
• - Purification Techniques: Methods used to isolate and purify synthesized conjugates effectively.
• - Analytical Methods: Strategies for characterizing the purity and quality of peptide conjugates.

The featured speaker, Dr. Yuyan Chen, Senior Director of Chemistry at BioDuro, will lead discussions on how synthesis strategies are applied in practice, illustrated through pertinent case studies. These case studies will shed light on how decisions made during synthesis impact overall project execution, timelines, and purity levels.

Connecting with Broader Scientific Principles

In addition to synthesis methodologies, the session will connect peptide synthesis with broader biological and chemical principles, particularly focusing on peptide DNA-encoded libraries (DEL), which are pivotal in identifying novel therapeutic candidates. By understanding these connections, participants will gain insights into the multi-faceted development landscape of complex peptide conjugates.

Register for Insights

If you are keen to expand your knowledge and stay at the forefront of peptide technology, registering for this webinar on Friday, October 30, 2026, at 11 AM EDT (4 PM CET/EU-Central) is a must.

To register and learn more about this informative session, visit the Xtalks event page. This is an excellent opportunity for professionals in the pharmaceuticals and biotech sectors to enhance their understanding of peptide conjugate synthesis and its implications for therapeutic development.

About Xtalks

Xtalks serves as a crucial platform within the life sciences, providing thought leadership, timely insights, and collaborative opportunities for professionals in pharma, biotech, medtech, and healthcare. Their offerings include news, webinars, and expert interviews that enable informed decision-making in a rapidly evolving field.

Stay tuned and involved in this exciting area of research and development by joining the Xtalks community. For more information, visit the Xtalks website.